↓ Skip to main content

Dove Medical Press

Article Metrics

Zolav®: a new antibiotic for the treatment of acne [Corrigendum]

Overview of attention for article published in Drug Design, Development and Therapy, April 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 tweeters
Title
Zolav®: a new antibiotic for the treatment of acne [Corrigendum]
Published in
Drug Design, Development and Therapy, April 2016
DOI 10.2147/dddt.s109682
Pubmed ID
Authors

Ramiz Boulos, Alexa Dinant

Abstract

[This corrects the article on p. 1235 in vol. 10.].

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2016.
All research outputs
#5,544,545
of 7,695,064 outputs
Outputs from Drug Design, Development and Therapy
#456
of 995 outputs
Outputs of similar age
#171,713
of 267,406 outputs
Outputs of similar age from Drug Design, Development and Therapy
#25
of 62 outputs
Altmetric has tracked 7,695,064 research outputs across all sources so far. This one is in the 24th percentile – i.e., 24% of other outputs scored the same or lower than it.
So far Altmetric has tracked 995 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,406 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.